Future Trends in Ophthalmic Drug Development
Gene therapy integration is transforming the Common Drugs Use In Ophthalmology Market through one-time treatments for inherited retinal diseases. Voretigene neparvovec for RPE65 mutation-associated retinal dystrophy established the gene therapy precedent. CRISPR-based editing approaches target common mutations causing inherited blindness. The Common Drugs Use In Ophthalmology Market anticipates...
0 Comments 0 Shares 207 Views 0 Reviews